Antigens from Leishmania amastigotes inducing clinical remission of psoriatic arthritis

Archives of Dermatological Research

Volumn 303, Issue 6, 2011, Pages 399-415

  O'Daly, J A ^a,b,c   Gleason, J ^a   Lezama, R ^b   Rodriguez, P J ^b   Silva, E ^b   Indriago, N R ^b  

^a Astralis Ltd   (United States)

^b Center for Psoriasis Research and Treatment   (Venezuela)

^c INSTITUTO VENEZOLANO DE INVESTIGACIONES CIENTÍFICAS   (Venezuela)

Author keywords

Amastigote antigens; Clinical trial; Immunotherapy; Leishmaniasis; Psoriasis; Psoriatic arthritis

Indexed keywords

AS 100 1; AS 100 1 ANTIGEN; BACTERIAL ANTIGEN; LEISHMANIA VACCINE; UNCLASSIFIED DRUG;

AMASTIGOTE; ARTICLE; CD3+ T LYMPHOCYTE; CD4 CD8 RATIO; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL ACTIVATION; CELL COUNT; CELL FUNCTION; CELL PROLIFERATION; CLINICAL TRIAL; CONCENTRATION RESPONSE; CONTROLLED STUDY; DISEASE DURATION; DISEASE SEVERITY; DRUG EFFICACY; DRUG SAFETY; FLOW CYTOMETRY; HEAT SENSATION; HLA SYSTEM; HUMAN; HUMAN CELL; INFLAMMATION; INJECTION SITE ERYTHEMA; INJECTION SITE NODULE; INJECTION SITE PAIN; LEISHMANIA; MAJOR CLINICAL STUDY; OPTIMAL DRUG DOSE; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; PSORIATIC ARTHRITIS; REMISSION; SCORING SYSTEM; SIDE EFFECT; SINGLE BLIND PROCEDURE; TREATMENT OUTCOME; VACCINATION;

ADOLESCENT; ADULT; AGED; ANTIGENS, CD; ANTIGENS, PROTOZOAN; ARTHRITIS, PSORIATIC; CD8-POSITIVE T-LYMPHOCYTES; CELL MOVEMENT; CELL PROLIFERATION; CELL SEPARATION; CHILD; CHILD, PRESCHOOL; DISEASE PROGRESSION; FEMALE; FLOW CYTOMETRY; HUMANS; IMMUNOPHENOTYPING; LEISHMANIA; LYMPHOCYTE SUBSETS; MALE; MIDDLE AGED; PROTOZOAN VACCINES; REMISSION INDUCTION; SEVERITY OF ILLNESS INDEX;

EID: 79960704539     PISSN: 03403696     EISSN: 1432069X     Source Type: Journal    
DOI: 10.1007/s00403-011-1133-0     Document Type: Article

References (64)

1. A Amherd-Hoekstra H Näher HM Lorenz, et al. 2010 Psoriatic arthritis: a review J Dtsch Dermatol Ges 8 332 339 20015187 10.1111/j.1610-0387. 2009.07334-supp.x
2. AC Barton 2002 Genetic epidemiology. Psoriatic arthritis Arthritis Res 4 247 251 12106495 10.1186/ar415 (Pubitemid 34716305)
3. DL Boyle A Kavanaugh 2008 The pathobiology of psoriatic synovium Curr Opin Rheumatol 20 404 407 18525352 10.1097/BOR.0b013e32830435a7
4. JM Brewer 2006 (How) do aluminium adjuvants work? Immunol Lett 102 10 15 16188325 1:CAS:528:DC%2BD2MXht1SksrbJ 10.1016/j.imlet.2005.08.002 (Pubitemid 41606034)
5. JE Brockbank M Stein CT Schentag, et al. 2005 Dactylitis in psoriatic arthritis: a marker for disease severity? Ann Rheum Dis 64 188 190 15271771 1:STN:280:DC%2BD2M%2FitVOqsA%3D%3D 10.1136/ard.2003.018184 (Pubitemid 40193609)
6. SE Cassell JD Bieber P Rich, et al. 2007 The modified nail psoriasis severity index: validation of an instrument to assess psoriatic nail involvement in patients with psoriatic arthritis J Rheumatol 2007 34 123 129 (Pubitemid 46106572)
7. A Ceponis A Kavanaugh 2010 Treatment of psoriatic arthritis with biological agents Semin Cutan Med Surg 29 56 62 20430309 1:CAS:528: DC%2BC3cXhtVClt73J 10.1016/j.sder.2010.01.004
8. V Chandran A Gottlieb RJ Cook, et al. 2009 Psoriatic arthritis international multicenter psoriasis and psoriatic arthritis reliability trial for the assessment of skin, joints, nails, and dactylitis Arthritis Rheum 61 1235 1242 19714610 10.1002/art.24562
9. V Chandran SP Raychaudhuri 2010 Geoepidemiology and environmental factors of psoriasis and psoriatic arthritis J Autoimmun 34 314 321 10.1016/j.jaut.2009.12.001
10. V Chandran CT Schentag DD Gladman 2007 Sensitivity of the classification of psoriatic arthritis criteria in early psoriatic arthritis Arthritis Rheum 57 1560 1563 18050230 10.1002/art.23104 (Pubitemid 350308858)
11. YT Chang TJ Chen PC Liu, et al. 2009 Epidemiological study of psoriasis in the national health insurance database in Taiwan Acta Derm Venereol 89 262 266 19479122 10.2340/00015555-0642
12. E Choy 2007 T cells in psoriatic arthritis Curr Rheumatol Rep 9 437 441 18177595 1:CAS:528:DC%2BD2sXhsVKgsL%2FJ 10.1007/s11926-007-0071-5 (Pubitemid 350305199)
13. MK Choy ME Phipps 2010 MICA polymorphism: biology and importance in immunity and disease Trends Mol Med 16 97 106 20153697 1:CAS:528: DC%2BC3cXjt1Wiu7w%3D 10.1016/j.molmed.2010.01.002
14. E Christophers JN Barker CE Griffiths, et al. 2010 The risk of psoriatic arthritis remains constant following initial diagnosis of psoriasis among patients seen in European dermatology clinics J Eur Acad Dermatol Venereol 24 548 554 19874432 1:STN:280:DC%2BC3czosFerug%3D%3D 10.1111/j.1468-3083.2009. 03463.x
15. DH Ciocon AB Kimball 2007 Psoriasis and psoriatic arthritis: separate or one and the same? Br J Dermatol 157 850 860 17725671 1:CAS:528: DC%2BD2sXhtlyrsLjP 10.1111/j.1365-2133.2007.08148.x (Pubitemid 47583502)
16. LC Coates PS Helliwell 2008 Classification and categorization of psoriatic arthritis Clin Rheumatol 27 1211 1216 18629574 10.1007/s10067-008- 0947-4
17. P Costello B Bresnihan C O'Farrelly, et al. 1999 Predominance of CD8+ T lymphocytes in psoriatic arthritis J Rheumatol 26 1117 1124 10332977 1:STN:280:DyaK1M3mtlOksA%3D%3D (Pubitemid 29215077)
18. JT Elder 2009 Genome-wide association scan yields new insights into the immunopathogenesis of psoriasis Genes Immun 10 201 209 19262574 1:CAS:528:DC%2BD1MXkvVSru7w%3D 10.1038/gene.2009.11
19. M Englbrecht Y Wang M Ronneberger, et al. 2010 Measuring joint involvement in polyarticular psoriatic arthritis: an introduction of alternatives Arthritis Care Res 62 977 983 1:STN:280:DC%2BC3cnlvFOmsg%3D%3D 10.1002/acr.20161
20. G Filaci D Fenoglio F Indiveri 2011 CD8(+) T regulatory/suppressor cells and their relationships with autoreactivity and autoimmunity Autoimmunity 44 51 57 20670118 1:CAS:528:DC%2BC3MXlt1ymuw%3D%3D 10.3109/08916931003782171
21. G Filaci M Rizzi M Setti, et al. 2005 Non-antigen-specific CD8(+) T suppressor lymphocytes in diseases characterized by chronic immune responses and inflammation Ann N Y Acad Sci 1050 115 123 16014526 1:CAS:528: DC%2BD2MXhtVWgtr3K 10.1196/annals.1313.013 (Pubitemid 41129428)
22. AM Fink E Cauza W Hassfeld, et al. 2007 Vascular endothelial growth factor in patients with psoriatic arthritis Clin Exp Rheumatol 25 305 308 17543159 1:STN:280:DC%2BD2szjtF2mtg%3D%3D (Pubitemid 46851437)
23. O FitzGerald R Winchester 2009 Psoriatic arthritis: from pathogenesis to therapy Arthritis Res Ther 11 214 223 19232079 10.1186/ar2580
24. SE Gabriel K Michaud 2009 Epidemiological studies in incidence, prevalence, mortality, and comorbidity of the rheumatic diseases Arthritis Res Ther 11 229 245 19519924 10.1186/ar2669
25. S González J Martínez-Borra A López-Vázquez, et al. 2002 MICA rather than MICB, TNFA, or HLA-DRB1 is associated with susceptibility to psoriatic arthritis J Rheumatol 29 973 978 12022360 (Pubitemid 34493503)
26. EMG Griffiths JN Barker 2007 Pathogenesis and clinical features of psoriasis Lancet 370 263 271 17658397 1:CAS:528:DC%2BD2sXnvF2gs7w%3D 10.1016/S0140-6736(07)61128-3 (Pubitemid 47069537)
27. G Ibrahim R Waxman PS Helliwell 2009 The prevalence of psoriatic arthritis in people with psoriasis Arthritis Rheum 61 1373 1378 19790120 1:STN:280:DC%2BD1MnovVShtg%3D%3D 10.1002/art.24608
28. C Jandus G Bioley JP Rivals, et al. 2008 Increased numbers of circulating polyfunctional Th17 memory cells in patients with seronegative spondylarthritides Arthritis Rheum 58 2307 2317 18668556 10.1002/art.23655
29. M Kemp MB Hansen TG Theander 1992 Recognition of Leishmania antigens by T lymphocytes from nonexposed individuals Infect Immun 60 2246 2251 1534072 1:CAS:528:DyaK38XksVKns7Y%3D
30. OH Lowry NJ Rosebrough AL Farr RJ Randall 1951 Protein measurement with the folin phenol reagent J Biol Chem 193 1 265 275 14907713 1:CAS:528: DyaG38XhsVyrsw%3D%3D
31. H Maciejewska A Jüngel RE Gay, et al. 2009 Innate immunity, epigenetics and autoimmunity in rheumatoid arthritis Mol Immunol 47 12 18 10.1016/j.molimm.2009.01.010
32. D McGonagle RJU Lories AL Tan, et al. 2007 The concept of a "synovio-entheseal complex" and its implications for understanding joint inflammation and damage in psoriatic arthritis and beyond Arthritis Rheum 56 2482 2491 17665450 10.1002/art.22758 (Pubitemid 47237267)
33. D McGonagle 2009 Enthesitis: an autoinflammatory lesion linking nail and joint involvement in psoriatic disease J Eur Acad Dermatol Venereol 23 9 13 19686380 1:CAS:528:DC%2BC3cXlsVSisro%3D 10.1111/j.1468-3083.2009.03363.x
34. P Mease 2006 Psoriatic arthritis update Bull NYU Hosp Jt Dis 64 25 31 17121486 (Pubitemid 44659366)
35. PJ Mease 2010 Psoriatic arthritis: pharmacotherapy update Curr Rheumatol Rep 12 272 280 20490726 1:CAS:528:DC%2BC3cXht1CjsbrF 10.1007/s11926-010-0108-z
36. U Mrowietz K Reich 2009 Psoriasis-new insights into pathogenesis and treatment Dtsch Arztebl Int 106 11 19 19564982
37. U Mrowietz JT Elder J Barker 2007 The importance of disease associations and concomitant therapy for the long term management of psoriasis patients Arch Dermatol Res 298 309 319 10.1007/s00403-006-0707-8
38. JA O'Daly J Gleason 2010 Antigens from Leishmania amastigotes inducing clinical remission of psoriasis: relationship between leishmaniasis and psoriasis DERMA 1 47 57
39. JA O'Daly JP Gleason G Peña, et al. 2010 Purified proteins from leishmania amastigotes-induced delayed type hypersensitivity reactions and remission of collagen-induced arthritis in animal models Arch Dermatol Res 302 567 581 20063004 10.1007/s00403-009-1026-7
40. JA O'Daly R Lezama J Gleason 2009 Isolation of Leishmania amastigote protein fractions which induced lymphocyte stimulation and remission of psoriasis Arch Dermatol Res 301 411 427 19294395 10.1007/s00403-009-0940-z
41. JA O'Daly R Lezama PJ Rodriguez, et al. 2009 Antigens from Leishmania amastigotes induced clinical remission of psoriasis Arch Dermatol Res 301 1 13 18777031 10.1007/s00403-008-0883-9
42. JA O'Daly B Rodriguez T Ovalles, et al. 2010 Lymphocyte subsets in peripheral blood of patients with psoriasis before and after treatment with leishmania antigens Arch Dermatol Res 302 95 104 19707779 10.1007/s00403-009- 0992-0
43. JA O'Daly MB Rodriguez 1988 Differential growth requirements of several leishmania spp in chemically defined culture media Acta Trop Basel 45 109 126 2901198
44. MA Radtke K Reich C Blome, et al. 2009 Prevalence and clinical features of psoriatic arthritis and joint complaints in patients with psoriasis: results of a German national survey J Eur Acad Dermatol Venereol 23 683 691 19309433 1:STN:280:DC%2BD1MvhsFyqug%3D%3D 10.1111/j.1468-3083.2009.03159.x
45. R Rajesh KD Moudgil 2009 Heat-shock proteins can promote as well as regulate autoimmunity Autoimmun Rev 8 388 393 10.1016/j.autrev.2008.12.004
46. K Reich K Kruger R Mossner, et al. 2009 Epidemiology and clinical pattern of psoriatic arthritis in Germany: a prospective interdisciplinary epidemiological study of 1511 patients with plaque-type psoriasis Br J Dermatol 160 1040 1047 19210498 1:STN:280:DC%2BD1MzisVOguw%3D%3D 10.1111/j.1365-2133. 2008.09023.x
47. AC Rimaniol G Gras P Clayette 2007 In vitro interactions between macrophages and aluminum-containing adjuvants Vaccine 25 6784 6792 17689842 1:CAS:528:DC%2BD2sXpvF2qs78%3D 10.1016/j.vaccine.2007.06.051 (Pubitemid 47332724)
48. AC Rimaniol G Gras F Verdier, et al. 2004 Aluminum hydroxide adjuvant induces macrophage differentiation towards a specialized antigen-presenting cell type Vaccine 22 3127 3135 15297065 1:CAS:528:DC%2BD2cXmsVCqt7s%3D 10.1016/j.vaccine.2004.01.061 (Pubitemid 39037217)
49. M Rozenblit M Lebwohl 2009 New biologics for psoriasis and psoriatic arthritis Dermatol Ther 22 56 60 19222517 10.1111/j.1529-8019.2008.01216.x
50. TP Saber CT Ng G Renard, et al. 2010 Remission in psoriatic arthritis: is it possible and how can it be predicted? Arthritis Res Ther 12 R94 20482783 10.1186/ar3021
51. P Sala E Tonutti C Feruglio, et al. 1993 Persistent expansions of CD4+ CD8+ peripheral blood T cells Blood 82 1546 1552 8364204 1:STN:280: DyaK3sznt1emsA%3D%3D (Pubitemid 23263972)
52. C Salliot E Dernis F Lavie, et al. 2009 Diagnosis of peripheral psoriatic arthritis: recommendations for clinical practice based on data from the literature and experts opinion Joint Bone Spine Joint Bone Spine 76 532 539
53. PK Smith RI Krohn GT Hermanson, et al. 1985 Measurement of protein using bicinchoninic acid Anal Biochem 150 76 85 3843705 1:CAS:528:DyaL2MXlsFKksL0%3D 10.1016/0003-2697(85)90442-7 (Pubitemid 16258399)
54. ER Soriano J Rosa 2009 Update on the treatment of peripheral arthritis in psoriatic arthritis Curr Rheumatol Rep 11 270 277 19691930 1:CAS:528: DC%2BC3cXhtFeku7vL 10.1007/s11926-009-0038-9
55. W Taylor D Gladman P Helliwell, et al. 2006 Classification criteria for psoriatic arthritis: development of new criteria from a large international study Arthritis Rheum 54 2665 2673 16871531 10.1002/art.21972 (Pubitemid 44205029)
56. WK Tonui JS Mejia L Hochberg, et al. 2004 Immunization with Leishmania major exogenous antigens protects susceptible BALB/c mice against challenge infection with L major Infect Immun 72 5654 5661 15385463 1:CAS:528: DC%2BD2cXotFaltb8%3D 10.1128/IAI.72.10.5654-5661.2004 (Pubitemid 39303674)
57. A Trautmann B Rückert P Schmid-Grendelmeier, et al. 2003 Human CD8 T cells of the peripheral blood contain a low CD8 expressing cytotoxic/effector subpopulation Immunology 108 305 312 12603596 1:CAS:528:DC%2BD3sXitlSksLw%3D 10.1046/j.1365-2567.2003.01590.x (Pubitemid 36332388)
58. M Ulanova A Tarkowski M Hahn-Zoric, et al. 2001 The common vaccine adjuvant aluminum hydroxide up-regulates accessory properties of human monocytes via an interleukin-4-dependent mechanism Infect Immun 69 1151 1159 11160013 1:CAS:528:DC%2BD3MXns1WhtQ%3D%3D 10.1128/IAI.69.2.1151-1159.2001 (Pubitemid 32109584)
59. AW van Kuijk P Reinders-Blankert TJ Smeets, et al. 2006 Detailed analysis of the cell infiltrate and the expression of mediators of synovial inflammation and joint destruction in the synovium of patients with psoriatic arthritis: implications for treatment Ann Rheum Dis 65 1551 1557 16728461 10.1136/ard.2005.050963 (Pubitemid 44799664)
60. W Weger 2010 Current status and new developments in the treatment of psoriasis and psoriatic arthritis with biological agents Br J Pharmacol 160 810 820 20590580 1:CAS:528:DC%2BC3cXpsVKnsbk%3D
61. R Winchester G Minevich D Kane, et al. 2008 Heterogeneity of the psoriasis phenotype revealed by HLA class I haplotype associations in psoriatic arthritis and psoriasis Clin Immunol 127 S88 S89 10.1016/j.clim.2008.03.247
62. R Winchester 2004 The genetics of autoimmune-mediated rheumatic diseases: clinical and biologic implications Rheum Dis Clin North Am 30 213 227 15061576 10.1016/S0889-857X(03)00112-1 (Pubitemid 38236185)
63. U Wollina L Unger B Heinig T Kittner 2010 Psoriatic arthritis Dermatol Ther 23 123 136 20415819 10.1111/j.1529-8019.2010.01306.x
64. U Zügel SHE Kaufmann 1999 Role of heat shock proteins in protection from and pathogenesis of infectious diseases Clin Microbiol Rev 12 19 39 9880473 (Pubitemid 29055952)